Background and Objectives: Consequences due to infection with SARS-CoV-2 virus can
have a direct impact on skeletal muscle, due to the fact that both cardiac and skeletal muscle …

Abstract In 2019-2020, the SARS-CoV-2 pandemic has shocked the world and most health
care systems, and a “second wave” of the viral spread is ongoing in Europe and in Italy too …

Introduction It has become increasingly evident that COVID-19 contributes to multiorgan
pathophysiology. The systemic inflammatory response increases both pro-inflammatory …

In long coronavirus disease 2019 (long COVID‐19), involvement of the musculoskeletal
system is characterised by the persistence or appearance of symptoms such as fatigue …

COVID-19, a disease caused by the novel coronavirus SARS-CoV-2, has been drastically
affecting the daily lives of millions of people. COVID-19 is described as a multiorgan disease …

The new coronavirus, which causes the infectious disease named COVID-19 by the World
Health Organization (WHO), was notified in 2020 in China. The main clinical manifestations …

Background: Intensive care patients commonly develop muscle wasting and functional
impairment. However, the role of severe COVID-19 in the magnitude of muscle wasting and …

Both laboratory investigations and body composition quantification measures (eg, computed
tomography, CT) portray muscle loss in symptomatic Coronavirus disease 2019 (COVID-19) …

Myopathy is a disease characterized by muscle dysfunction in general and may be
associated with genetics, medication such as statins, or inflammation. In 2019, an epidemic …

The impact of COVID-19 has been largely described after symptom development. Although
the SARS-CoV-2 virus elevates heart rate (HR) prior to symptom onset, whether this virus …